|
Tikagrelor Teva 90 mg tbl flm 90x1x90 mg (blis.OPA/Al/PVC-Al - jednotk.bal.)
90 mg
|
Filmom obalená tableta |
B01AC24
|
Teva B.V. |
—
|
|
Tikagrelor Teva 90 mg tbl flm 90x1x90 mg (blis.PVC/PVDC-Al - jednotk.bal.)
90 mg
|
Filmom obalená tableta |
B01AC24
|
Teva B.V. |
—
|
|
Tisseel sol gtv 1x10 ml (5 ml+5 ml) (striek.inj.PP- Advanced Syringe Technology)
|
Roztok na tkanivové lepidlo |
B02BC30
|
Baxter Slovakia s.r.o. |
—
|
|
Tisseel sol gtv 1x10 ml (5 ml+5 ml) (striek.inj.PP- PRIMA)
|
Roztok na tkanivové lepidlo |
B02BC30
|
Baxter Slovakia s.r.o. |
—
|
|
Tisseel sol gtv 1x2 ml (1 ml+1 ml) (striek.inj.PP- Advanced Syringe Technology)
|
Roztok na tkanivové lepidlo |
B02BC30
|
Baxter Slovakia s.r.o. |
—
|
|
Tisseel sol gtv 1x2 ml (1 ml+1 ml) (striek.inj.PP- PRIMA)
|
Roztok na tkanivové lepidlo |
B02BC30
|
Baxter Slovakia s.r.o. |
—
|
|
Tisseel sol gtv 1x4 ml (2 ml+2 ml) (striek.inj.PP- Advanced Syringe Technology)
|
Roztok na tkanivové lepidlo |
B02BC30
|
Baxter Slovakia s.r.o. |
—
|
|
Tisseel sol gtv 1x4 ml (2 ml+2 ml) (striek.inj.PP- PRIMA)
|
Roztok na tkanivové lepidlo |
B02BC30
|
Baxter Slovakia s.r.o. |
—
|
|
Tocieta 25 mg tbl flm 14x1x25 mg (blis.OPA/Al/PVC-Al - jednotk.bal.)
25 mg
|
Filmom obalená tableta |
B02BX05
|
Zentiva, k.s. |
—
|
|
Tocieta 25 mg tbl flm 14x25 mg (blis.OPA/Al/PVC-Al)
25 mg
|
Filmom obalená tableta |
B02BX05
|
Zentiva, k.s. |
—
|
|
Tocieta 25 mg tbl flm 28x1x25 mg (blis.OPA/Al/PVC-Al - jednotk.bal.)
25 mg
|
Filmom obalená tableta |
B02BX05
|
Zentiva, k.s. |
—
|
|
Tocieta 25 mg tbl flm 28x25 mg (blis.OPA/Al/PVC-Al)
25 mg
|
Filmom obalená tableta |
B02BX05
|
Zentiva, k.s. |
—
|
|
Tocieta 25 mg tbl flm 84x1x25 mg (blis.OPA/Al/PVC-Al - jednotk.bal.)
25 mg
|
Filmom obalená tableta |
B02BX05
|
Zentiva, k.s. |
—
|
|
Tocieta 25 mg tbl flm 84x25 mg (blis.OPA/Al/PVC-Al)
25 mg
|
Filmom obalená tableta |
B02BX05
|
Zentiva, k.s. |
—
|
|
Tocieta 50 mg tbl flm 14x1x50 mg (blis.OPA/Al/PVC-Al - jednotk.bal.)
50 mg
|
Filmom obalená tableta |
B02BX05
|
Zentiva, k.s. |
—
|
|
Tocieta 50 mg tbl flm 14x50 mg (blis.OPA/Al/PVC-Al)
50 mg
|
Filmom obalená tableta |
B02BX05
|
Zentiva, k.s. |
—
|
|
Tocieta 50 mg tbl flm 28x1x50 mg (blis.OPA/Al/PVC-Al - jednotk.bal.)
50 mg
|
Filmom obalená tableta |
B02BX05
|
Zentiva, k.s. |
—
|
|
Tocieta 50 mg tbl flm 28x50 mg (blis.OPA/Al/PVC-Al)
50 mg
|
Filmom obalená tableta |
B02BX05
|
Zentiva, k.s. |
—
|
|
Tocieta 50 mg tbl flm 84x1x50 mg (blis.OPA/Al/PVC-Al - jednotk.bal.)
50 mg
|
Filmom obalená tableta |
B02BX05
|
Zentiva, k.s. |
—
|
|
Tocieta 50 mg tbl flm 84x50 mg (blis.OPA/Al/PVC-Al)
50 mg
|
Filmom obalená tableta |
B02BX05
|
Zentiva, k.s. |
—
|
|
Tracutil con inf 50x10 ml
|
Koncentrát na infúzny roztok (Infúzny koncentrát - platné do okt2020) |
B05XA30
|
B.Braun Melsungen AG |
—
|
|
Tracutil con inf 5x10 ml
|
Koncentrát na infúzny roztok (Infúzny koncentrát - platné do okt2020) |
B05XA30
|
B.Braun Melsungen AG |
—
|
|
Tranexamic acid Kabi 10 mg/ml sol inf 10x100 ml/1000 mg (fľ.PE (KabiPac))
10 mg/ml
|
Infúzny roztok |
B02AA02
|
Fresenius Kabi s.r.o. |
—
|
|
Tranexamic acid Kabi 10 mg/ml sol inf 10x50 ml/500 mg (fľ.PE (KabiPac))
10 mg/ml
|
Infúzny roztok |
B02AA02
|
Fresenius Kabi s.r.o. |
—
|